Company Filing History:
Years Active: 1998-2001
Title: The Innovative Contributions of Jill Cheng
Introduction
Jill Cheng is a prominent inventor based in Burlingame, CA (US). She has made significant contributions to the field of biotechnology, particularly in the area of protein tyrosine phosphatases. With a total of 5 patents to her name, Cheng's work has the potential to impact various aspects of medical research and treatment.
Latest Patents
One of her latest inventions focuses on protein tyrosine phosphatases of hematopoietic stem cells (PTP HSC). This invention concerns new non-receptor protein tyrosine phosphatases, specifically native murine and human PTP HSCs, their analogs in other mammals, and their functional derivatives. The invention also relates to nucleic acids encoding these proteins, vectors capable of expressing such nucleic acids, and recombinant host cells transformed with them. Additionally, her work includes assays for identifying agonists and antagonists of native PTP HSCs, methods for expanding undifferentiated stem cells, and techniques for inducing stem cell differentiation. Another notable patent involves antibodies that specifically bind to a novel .kappa./.mu.-like protein, designated as PTP .lambda., along with hybridoma cell lines producing these antibodies.
Career Highlights
Jill Cheng is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work at Genentech has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her contributions to scientific research.
Collaborations
One of her notable coworkers is Laurence A Lasky, with whom she has collaborated on various projects. Their combined expertise has led to advancements in understanding protein interactions and their implications in health and disease.
Conclusion
Jill Cheng's innovative work in the field of biotechnology, particularly her patents related to protein tyrosine phosphatases, showcases her significant contributions to medical research. Her ongoing efforts at Genentech, Inc. continue to pave the way for future advancements in the industry.